These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4344248)

  • 21. Comparison of effects of gastrin, cholecystokinin-pancreozymin, secretin, and glucagon on human stomach muscle in vitro.
    Cameron AJ; Phillips SF; Summerskill WH
    Gastroenterology; 1970 Oct; 59(4):539-45. PubMed ID: 5477749
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for and some properties of a 3', 5'-cyclic AMP phosphodiesterase inhibitor in potato.
    Shimoyama M; Kawai M; Tanigawa Y; Ueda I
    Biochem Biophys Res Commun; 1972 Apr; 47(1):59-65. PubMed ID: 4337428
    [No Abstract]   [Full Text] [Related]  

  • 24. The action of gastrin and cholecystokinin-related peptides on pancreatic secretion in the rat.
    Dockray GJ
    Q J Exp Physiol Cogn Med Sci; 1973 Apr; 58(2):163-9. PubMed ID: 4487966
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of cholecystokinin, secretin, 2-deoxy-D-glucose and insulin on pentagastrin-stimulated gastric secretion in fistula chickens.
    Burhol PG
    Scand J Gastroenterol; 1974; 9(1):55-8. PubMed ID: 4616329
    [No Abstract]   [Full Text] [Related]  

  • 26. Alterations in membrane transport produced by diarrheogenic non-beta islet cell tumors of the pancreas.
    Kraft AR; Tompkins RK; Endahl GL; Zollinger RM
    Surg Forum; 1969; 20():338-40. PubMed ID: 4315506
    [No Abstract]   [Full Text] [Related]  

  • 27. Factors affecting gallbladder motility in sheep.
    Pass MA; Heath TJ
    Comp Biochem Physiol C Comp Pharmacol; 1977; 56(2):127-31. PubMed ID: 15772
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of cholecystokinin-octapeptide, caerulein, and pentagastrin on epithelial cell proliferation in the murine gallbladder.
    Lamote J; Putz P; Willems G
    Gastroenterology; 1982 Aug; 83(2):371-7. PubMed ID: 6177575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of intravenous cholecystokinin, secretin and pentagastrin on electromyographic activity of the rumen in sheep.
    Kermani RZ; Rezaiee A
    Regul Pept; 1993 Jun; 45(3):371-7. PubMed ID: 8351402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contribution to the study of hormonal regulation of pancreatic secretin in the rabbit].
    Murillo A; López MA
    Rev Esp Fisiol; 1971 Jun; 27(2):131-8. PubMed ID: 5566948
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation and characterization of multiple forms of cyclic nucleotide phosphodiesterase from liver.
    Terasaki WL; Russell TR; Appleman MM
    Methods Enzymol; 1974; 38():257-9. PubMed ID: 4375757
    [No Abstract]   [Full Text] [Related]  

  • 32. Phosphatases from rice bran.
    Sastry BS; Rao MR
    Indian J Biochem Biophys; 1972 Dec; 9(4):297-303. PubMed ID: 4350895
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of cholecystokinin, gastrin, and glucagon on human gallbladder muscle in vitro.
    Cameron AJ; Phillips SF; Summerskill WH
    Proc Soc Exp Biol Med; 1969 May; 131(1):149-54. PubMed ID: 5770089
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver low-Km, hormone-sensitive phosphodiesterase.
    Loten EG
    Methods Enzymol; 1988; 159():736-44. PubMed ID: 2842635
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of activation of a cyclic adenosine 3':5'-monophosphate phosphodiesterase from bovine heart by calcium ions. Identification of the protein activator as a Ca2+ binding protein.
    Teo TS; Wang JH
    J Biol Chem; 1973 Sep; 248(17):5950-5. PubMed ID: 4353626
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
    Pöch G; Kukovetz WR
    Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of exogenous secretin and cholecystokinin (CCK) on pentagastrin-stimulated intrinsic factor (IF) secretion in man.
    Vatn MH; Berstad A; Myren J
    Scand J Gastroenterol; 1974; 9(3):313-18. PubMed ID: 4605241
    [No Abstract]   [Full Text] [Related]  

  • 38. Further studies on the effect of cholecystokinin and secretin on the content of cyclic AMP, cyclic GMP, protein and calcium in pure pancreatic juice of dogs.
    Singer MV; Cailla H
    Z Gastroenterol; 1980 May; 18(5):265-73. PubMed ID: 6254284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spontaneous motility and the action of cholecystokin pancreozymin, secretin, and agastrin on the canine extrahepatic biliary tract in vitro.
    Toouli J; Watts JM; Dudley HA
    Br J Surg; 1970 Nov; 57(11):858. PubMed ID: 5482300
    [No Abstract]   [Full Text] [Related]  

  • 40. Evidence that acetylcholine released by gastrin and related polypeptides contributes to their effect on gastrointestinal motility.
    Vizi SE; Bertaccini G; Impicciatore M; Knoll J
    Gastroenterology; 1973 Feb; 64(2):268-77. PubMed ID: 4686335
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.